
2026-04-07
Chithandizo cha khansa ya m'chiwindi ku China 2026 chasintha kukhala nthawi yoyendetsedwa bwino, ikuyang'ana kwambiri kuchepetsa kubwereza pambuyo pa opareshoni kudzera pakuyika pachiwopsezo komanso machiritso ophatikizana. Khansa ya chiwindi, makamaka hepatocellular carcinoma (HCC), tsopano ikugwiritsidwa ntchito pogwiritsa ntchito immunotherapy, mankhwala omwe akugwiritsidwa ntchito, ndi njira zowonongeka zomwe zimapangidwira kuopsa kwa munthu mobwerezabwereza. Kugwirizana kwaposachedwa kwa akatswiri mu 2026 kukugogomezera kuzindikira odwala omwe ali pachiwopsezo choyambilira ndikugwiritsa ntchito njira zamankhwala monga PD-1 inhibitors ophatikizidwa ndi anti-angiogenic agents kuti apititse patsogolo kwambiri kupulumuka.
Malo a khansa ya chiwindi Kuwongolera ku China kwasintha kwambiri ndi 2026. Moyendetsedwa ndi kafukufuku wambiri wachipatala komanso kutulutsidwa kwa "2026 Expert Consensus on Postoperative Adjuvant Therapy for Hepatocellular Carcinoma," ndondomeko zachipatala tsopano zakhala zodziwika kwambiri. Mfundo yaikulu ya filosofi yasuntha kuchoka ku njira yofanana ndi imodzi kupita ku njira yokhazikika pa chiopsezo chokhazikika.
M'mbiri, ziwopsezo za kubwereranso pambuyo pa opaleshoni zidakwera pakati pa 50% ndi 70%. Komabe, deta yatsopano imasonyeza kuti kuphatikiza chithandizo chamankhwala ndi njira zothandizira m'deralo zingathe kuchepetsa kwambiri ziwerengerozi. Malangizo a 2026 akuwonetsa mitundu iwiri yosiyana ya kubwereza: kubwereza koyambirira (pasanathe zaka ziwiri) ndi kubwereza mochedwa (pambuyo pa zaka ziwiri). Iliyonse imafunikira njira yochiritsira yosiyana.
Kubwereranso koyambirira nthawi zambiri zimagwirizanitsidwa ndi ma micro-metastases omwe amapezeka asanachite opaleshoni kapena kufalitsa intraoperative. Mosiyana, kubwereza mochedwa kawirikawiri zimachokera ku zotupa za de novo zomwe zimayamba chifukwa cha matenda aakulu a chiwindi, monga hepatitis B kapena cirrhosis. Kuzindikira kusiyana kumeneku ndikofunikira pakusankha chithandizo choyenera cha adjuvant.
Madokotala tsopano amagwiritsa ntchito njira zenizeni kuti azindikire odwala omwe amafunikira chithandizo chaukali adjuvant mwamsanga pambuyo pa opaleshoni. Zomwe zili pachiwopsezo chachikulu ndi izi:
Odwala omwe akuwonetsa izi amawerengedwa kuti ndi omwe amafunikira chithandizo chamankhwala champhamvu, kuphatikiza ma immunotherapy ndi othandizira omwe akuwunikiridwa.
Kuti abwererenso mochedwa, cholinga chake chimasinthiratu ndikuwongolera matenda am'chiwindi. Othandizira kwambiri akuphatikizapo:
Utsogoleri wa gululi umayika patsogolo chithandizo chanthawi yayitali cha antiviral ndikuwunika pafupipafupi kuti mupewe chotupa chatsopano.
Chimodzi mwazosintha zofunikira kwambiri muupangiri wa 2026 ndikuphatikiza kovomerezeka kwa systemic antitumor therapy mumayendedwe adjuvant. Izi zikuwonetsa kulowa kwa khansa ya chiwindi chithandizo mu "nthawi yolimbana ndi chitetezo chamthupi". M'mbuyomu, mankhwala osokoneza bongo amasungidwa pamilandu yapamwamba, yosasinthika. Tsopano, iwo proactively ntchito kuthetsa yotsalira tizilombo tosaoneka matenda.
Mayesero aposachedwa azachipatala awonetsa kuti kuphatikiza ma immune checkpoint inhibitors (ICIs) ndi tyrosine kinase inhibitors (TKIs) kapena anti-VEGF antibodies kumabweretsa zotsatira zapamwamba poyerekeza ndi monotherapy. Njira ya "T+A" (Atezolizumab kuphatikiza Bevacizumab) ndi zophatikizira zapakhomo monga Donafenib kuphatikiza Toripalimab zawonetsa zotsatira zabwino pakukulitsa Kupulumuka Kwaulere Kwambiri (RFS).
Kwa odwala omwe ali pachiwopsezo chachikulu, immunotherapy yokhala ndi single-agent yokhala ndi mankhwala monga Sintilimab kapena Nivolumab yatsimikiziranso kuti ndi yothandiza. Mankhwalawa amathandizira kubwezeretsa chitetezo chamthupi kuti azindikire ndikuwononga maselo a khansa omwe atsala. Mgwirizano wa 2026 umanena kuti mankhwalawa salinso oyesera koma akulimbikitsidwa kuti asankhe magulu omwe ali pachiwopsezo chachikulu.
Deta yomwe yaperekedwa pamisonkhano yaposachedwa yamaphunziro ku Shanghai ikuwonetsa kuti mankhwala ena omwe akuwunikiridwa amatha kukwaniritsa chiwopsezo cha chaka chimodzi cha RFS kuyandikira 87% mwa anthu omwe ali pachiwopsezo chachikulu. Kuphatikiza apo, ma regimens ophatikizira odwala omwe ali ndi zotupa zazikulu (> 5 cm) ndi MVI adanenanso kuti kupulumuka kwa chaka chimodzi kupitilira 96%. Ziwerengerozi zikuyimira kusintha kwakukulu kuchokera ku zolemba zakale.
Komabe, kugwiritsa ntchito mankhwala amphamvuwa kumafuna kusankha mosamala odwala. Sikuti wodwala aliyense amapindula mofanana, ndipo kuthekera kwa zochitika zokhudzana ndi chitetezo cha mthupi (irAEs) zimafunikira dongosolo lolimba la chitetezo.
Ngakhale chithandizo chamankhwala chikukula, chithandizo cham'deralo chimakhalabe chofunikira mu 2026 algorithm yamankhwala. Kugwirizana komwe kwasinthidwa kumapereka malangizo abwino okhudza nthawi komanso momwe mungagwiritsire ntchito Transarterial Chemoembolization (TACE), Hepatic Arterial Infusion Chemotherapy (HAIC), ndi radiotherapy.
Kwa odwala omwe ali pachiwopsezo chachikulu, adjuvant TACE akulimbikitsidwa pafupifupi mwezi umodzi pambuyo pochotsa opaleshoni. Protocol yodziwika bwino imaphatikizapo maphunziro amodzi kapena awiri. Kusunga nthawi kumeneku kumapangitsa kuti chiwindi chizichira pambuyo pa opareshoni pomwe chimayang'ana ma metastases aliwonse otsala obwera ndi magazi. TACE imagwira ntchito podula magazi m'maselo otsala a chotupa ndikupereka mankhwala amphamvu kwambiri a chemotherapy kuchiwindi.
Chochititsa chidwi kwambiri pakusintha kwa 2026 ndi malingaliro enieni a HAIC kwa odwala omwe ali ndi Microvascular Invasion (MVI). Pogwiritsa ntchito ndondomeko ya FOLFOX, HAIC yasonyezedwa kuti ikuwongolera kwambiri RFS m'gulu ili. Mosiyana ndi TACE, yomwe imalimbitsa mitsempha, HAIC imalowetsa mosalekeza mankhwala a chemotherapy, kukhalabe ndi mankhwala osokoneza bongo m'matumbo a chotupa ndi zotsatira zochepa za machitidwe.
Mphepete mwa maopaleshoni ndi chizindikiro chofunikira kwambiri cha kubwereza. Kwa odwala omwe ali ndi malire ocheperako (≤1 cm), MVI yabwino, kapena portal vein tumor thrombus, Intensity-Modulated Radiation Therapy (IMRT) tsopano ndi chida chofunikira chothandizira. Radiotherapy bwino samatenthetsa chotupa bedi, kuchepetsa chiopsezo cha kubwereza kwa m'deralo. Ndiwofunika makamaka ngati opaleshoni ina sizingatheke.
Mgwirizano wa 2026 umatsimikizira kuti kuchiza chotupa ndi theka la nkhondo; Kuwongolera matenda a chiwindi ndikofunikanso. Njira iyi "yoyang'anira maphunziro onse" imatsimikizira kuti chilengedwe cha chiwindi sichilimbikitsa kukula kwa khansa yatsopano.
Popeza kuti ambiri a khansa ya chiwindi milandu ku China imalumikizidwa ndi Hepatitis B Virus (HBV), chithandizo chamoyo chonse cha antivayirasi sichingakambirane. Malangizowa amalamula kugwiritsa ntchito ma nucleos (t) mafananidwe amphamvu omwe ali ndi zopinga zazikulu, monga Entecavir kapena Tenofovir. Kupondereza kubwereza kwa ma virus sikumangoteteza chiwindi komanso kumachepetsa mwachindunji chiopsezo cha khansa.
Kwa odwala a Hepatitis C (HCV), ma antivayirasi (DAAs) amalangizidwa, ngakhale umboni wochulukirapo ukufunika kuti utsimikizire momwe zimakhudzira kupewa kuyambiranso pambuyo pa opaleshoni poyerekeza ndi chithandizo cha HBV.
Mankhwala ophatikizika akupitilizabe kugwira ntchito pazachipatala cha China. Mgwirizanowu umalimbikitsa Huaier Granule kwa odwala pambuyo pakuchotsa kwakukulu. Zowona zachipatala zikuwonetsa kuti zitha kulepheretsa kuyambiranso ndikutalikitsa moyo wonse, kukhala ngati chithandizo chothandizira limodzi ndi mankhwala ochiritsira.
Kupatula mankhwala apadera, njira yopangira chithandizo chamankhwala yakonzedwanso. Mtundu wa 2026 wa Barcelona Clinic Liver Cancer (BCLC), wotengedwa ku China, tsopano ukuphatikiza njira yopangira zisankho yomwe imadziwika kuti CUSE.
CUSE imayimira Kuvuta, Kusatsimikizika, Kugonjera, ndi Kutengeka. Ndondomekoyi ikutsogolera magulu amitundu yosiyanasiyana kuti aganizire mbali zinayi zofunika kwambiri:
Pophatikiza zinthu zaumunthu izi ndi umboni wachipatala, chimango cha CUSE chimatsimikizira kuti zosankha zachipatala zimakhala zoleza mtima, kupitilira njira zokhazikika zopangira chisamaliro chamunthu payekha.
Kusintha kwa 2026 BCLC kumabweretsa zosintha zingapo:
Pofuna kuthandiza odwala ndi mabanja kumvetsetsa zomwe mungasankhe, tebulo lotsatirali likufanizira njira zochiritsira zoyambilira zomwe zidalimbikitsidwa mu 2026.
| Chithandizo cha Makhalidwe | Makhalidwe Ofunikira | Njira Yabwino Yogwiritsira Ntchito |
|---|---|---|
| Immune Checkpoint Inhibitors (ICI) | Imayendetsa chitetezo chamthupi; kuthekera kwa kuyankha kokhazikika; chiopsezo cha zovuta zokhudzana ndi chitetezo cha mthupi. | Odwala omwe ali pachiwopsezo chachikulu chokhala ndi zifukwa zoyambilira; nthawi zambiri amaphatikizidwa ndi TKIs. |
| Tyrosine Kinase Inhibitors (TKI) | Zolinga za angiogenesis ndi njira za kukula kwa chotupa; kuwongolera pakamwa; zotsatira zoyipa. | Kukhazikitsa kwa adjuvant kwa magulu omwe ali pachiwopsezo chachikulu; chithandizo chamankhwala. |
| Transarterial Chemoembolization (TACE) | Kutumiza kwanuko kwa chemo + embolization; zowononga pang'ono; imafunikira mwayi wodutsa. | Odwala omwe ali pachiwopsezo chachikulu pambuyo pa opaleshoni; nthawi zambiri maphunziro 1-2 mkati mwa mwezi umodzi. |
| Hepatic Arterial Infusion (HAIC) | Kupitilira mlingo waukulu wa chemo kulowetsedwa; kuchepetsa zokhudza zonse kawopsedwe; ogwira mtima kuukira kwa mitsempha. | Odwala omwe ali ndi Microvascular Invasion (MVI); FOLFOX regimen yokonda. |
| Radiotherapy (IMRT/SBRT) | Kulunjika kwenikweni kwa radiation; osasokoneza; zothandiza kulamulira kwanuko. | Mipata yopapatiza yopangira opaleshoni (≤1 cm); portal mtsempha chotupa thrombus. |
Kuyenda ulendo wapambuyo pa opaleshoni kungakhale kovuta. Kutengera kuvomerezana kwaposachedwa, nayi njira yowongoka kwa odwala omwe akukumana nawo khansa ya chiwindi chithandizo ku China.
Kupeza chithandizo chamakono ndizovuta kwambiri kwa odwala. Mu 2026, mawonekedwe azachuma a khansa ya chiwindi chithandizo ku China chapita patsogolo kwambiri chifukwa cha kusintha kwa inshuwaransi ya dziko.
Kukula kofunikira ndikuphatikizidwa kwa zoletsa zingapo zapakhomo za PD-1 mu National Reimbursement Drug List (NRDL). Mankhwala monga Finolimab ndi ena awona zisonyezo zawo zikukulitsidwa kuti ziphimbe khansa ya chiwindi, zomwe zimapangitsa kuti zikhale zotsika mtengo kwa odwala wamba. Kusunthaku kwachepetsa kwambiri ndalama zotuluka m'thumba za immunotherapy, zomwe poyamba zinali zodula kwambiri.
Kuphatikiza apo, njira zochiritsira zomwe zimayang'aniridwa ndi njira zina zothanirana nazo m'deralo zimaperekedwa ndi inshuwaransi yoyambira yachipatala. Chiwongola dzanja chenichenicho chimasiyana malinga ndi dera komanso mtundu wa inshuwaransi yeniyeni, koma zomwe zikuchitika ndikufikira pakuperekedwa kwamankhwala amakono omwe atsimikiziridwa kuti atalikitsa moyo.
Ngakhale ndalama zenizeni zimasiyana malinga ndi chipatala ndi dera, odwala ayenera kuyembekezera ndalama zokhudzana ndi:
Odwala amalangizidwa kuti afunsane ndi ogwira ntchito m'chipatala kapena oyang'anira inshuwalansi kuti apindule kwambiri. Zipatala zambiri zapamwamba m'mizinda ngati Shanghai ndi Beijing zapereka madipatimenti kuti athandizire ndi inshuwaransi komanso mapulogalamu othandizira.
Kusankha chipatala choyenera ndikofunikira kuti mupeze zotsatira zabwino. China ili ndi mabungwe angapo apamwamba padziko lonse lapansi omwe amagwiritsa ntchito hepatobiliary oncology. "China Innovation Alliance for Hepato-Biliary Cancer," yomwe idakhazikitsidwa posachedwa, imalumikiza zipatala zapamwamba za 20 kuti zikhazikitse chisamaliro ndikulimbikitsa kafukufuku.
Zipatala zingapo ndizodziwika bwino chifukwa cha ukatswiri wawo pakukwaniritsa malangizo ogwirizana a 2026:
Pofunafuna chithandizo, odwala ayenera kutsimikizira ngati chipatala chikupereka:
Ngakhale kupita patsogolo kwa 2026 kukulonjeza, ndikofunikira kuyeza zabwino zomwe zingachitike.
Munda wa khansa ya chiwindi chithandizo ndi champhamvu. Kuyang'ana kupyola 2026, madera angapo ali okonzeka kuti apite patsogolo. Kukhazikitsidwa kwa nkhokwe zapadziko lonse ndi mabungwe ngati China Innovation Alliance for Hepato-Biliary Cancer kumathandizira zomwe zapezedwa ndi data.
Artificial Intelligence ikugwiritsidwa ntchito mochulukira kulosera zoopsa zomwe zingabwerenso komanso kukonza mapulani amankhwala. Mapulatifomu a digito amathandizira kuyang'anira kutali, kulola odwala kuti afotokoze zizindikiro zenizeni zenizeni, zomwe zimathandiza kuzindikira koyambirira kwa zovuta. Mutu wa "kupititsa patsogolo luso laukadaulo" womwe udawunikiridwa m'misonkhano yapachaka yaposachedwa yamaphunziro ukuwonetsa kusinthaku kwa chisamaliro chothandizidwa ndiukadaulo.
Kafukufuku akupitilira muzolinga zatsopano kupitilira PD-1/VEGF axis. Ma antibodies a Bispecific, chithandizo cha ma cell a CAR-T opangira zotupa zolimba, komanso katemera wochizira ali m'magawo osiyanasiyana azachipatala. Cholinga chake ndikusintha zotupa "zozizira" kukhala "zotentha" zomwe zimakhudzidwa kwambiri ndi immunotherapy.
Ofufuza aku China akugwira ntchito mwakhama ndi anzawo apadziko lonse lapansi. Maphunziro apakati okhudza mabungwe ochokera kumayiko angapo ayamba kufala, kuwonetsetsa kuti njira zochiritsira ku China zikugwirizana ndi njira zabwino zapadziko lonse lapansi ndikuthana ndi zochitika zapadera za miliri, monga kufalikira kwa HBV.
Chaka cha 2026 ndi nthawi yosintha khansa ya chiwindi chithandizo ku China. Ndi kutulutsidwa kwa mgwirizano wosinthidwa wa akatswiri ndi kuphatikizidwa kwa machitidwe apamwamba, odwala tsopano ali ndi mwayi wopeza njira zowonetsera, zogwira mtima, komanso zaumwini. Kusintha kwa kuphatikiza kwa systemic immunotherapy ndi kulowererapo komweko kumapereka chiyembekezo chatsopano chochepetsera kuchuluka kwa kuyambiranso pambuyo pa opaleshoni.
Chofunika kwambiri pakupita patsogolo kumeneku ndikugogomezera kuopsa kwa stratification, kuonetsetsa kuti odwala omwe ali pachiopsezo chachikulu amalandira chithandizo chaukali pamene odwala omwe ali pachiopsezo chochepa amapewa poizoni wosafunikira. Kuphatikizidwa ndi kasamalidwe kolimba ka antivayirasi komanso kuwongolera inshuwaransi, chiyembekezo cha odwala khansa ya chiwindi ndi chowala kuposa kale. Potengera luso la zipatala zapamwamba komanso kutsatira malangizo aposachedwa, odwala amatha kuyenda ulendo wawo wamankhwala ndi chidaliro komanso chiyembekezo.
Pamene kafukufuku akupitilirabe kusinthika komanso matekinoloje atsopano akutuluka, mgwirizano pakati pa asing'anga, ofufuza, ndi odwala ukhalabe womwe ukuchititsa kuti pakhale kusintha kwa moyo ndi moyo wabwino. Kwa aliyense wokhudzidwa khansa ya chiwindi, kukhalabe odziwa za zomwe zachitika posachedwa komanso kufunafuna chithandizo ku malo apadera ndi sitepe yofunika kwambiri kuti zinthu zitheke.